Last10K.com

La Jolla Pharmaceutical Co (LJPC) SEC Filing 10-K Annual report for the fiscal year ending Wednesday, December 31, 2014

La Jolla Pharmaceutical Co

HISTORY TOOLS
CIK: 920465 Ticker: LJPC
Document and Entity Information (USD $)
 12 Months Ended
Dec. 31, 2014
Feb. 27, 2015
Jun. 30, 2014
Document And Entity Information [Abstract]      
Entity Registrant Name LA JOLLA PHARMACEUTICAL CO    
Entity Central Index Key 0000920465    
Document Type 10-K    
Document Period End Date Dec. 31, 2014    
Amendment Flag false    
Document Fiscal Year Focus 2014    
Document Fiscal Period Focus FY    
Current Fiscal Year End Date --12-31    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Filer Category Accelerated Filer    
Entity Public Float     $ 76,360,000dei_EntityPublicFloat
Entity Common Stock, Shares Outstanding   15,243,340dei_EntityCommonStockSharesOutstanding  

View differences made from one year to another to evaluate La Jolla Pharmaceutical Co's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by La Jolla Pharmaceutical Co.

Continue

Assess how La Jolla Pharmaceutical Co's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

La Jolla Pharmaceutical Co's Definitive Proxy Statement (Form DEF 14A) filed after their 2015 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Material Contracts, Statements, Certifications & more

La Jolla Pharmaceutical Co provided additional information to their SEC Filing as exhibits

Exhibit 23.1: Consents Of Experts And Counsel
Exhibit 31.1: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 32.1: Section 1350 Certification
Ticker: LJPC
CIK: 920465
Form Type: 10-K Annual Report
Accession Number: 0000920465-15-000009
Submitted to the SEC: Mon Mar 16 2015 4:24:09 PM EST
Accepted by the SEC: Mon Mar 16 2015
Period: Wednesday, December 31, 2014
Industry: Biological Products No Disgnostic Substances

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/ljpc/0000920465-15-000009.htm